Inogen (INGN) Current Deferred Revenue (2013 - 2026)

Inogen (INGN) has 14 years of Current Deferred Revenue data on file, last reported at $5.1 million in Q1 2026.

• Quarterly Current Deferred Revenue fell 20.59% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (down 20.59% YoY) and the FY2025 annual result came in at $5.5 million, down 17.3% from the prior year.
• Current Deferred Revenue retreated to $5.1 million in Q1 2026 per INGN's latest filing, from $5.5 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $9.1 million in Q3 2022 and bottomed at $5.1 million in Q1 2026.
• The 5-year median for Current Deferred Revenue is $7.4 million (2024), against an average of $7.5 million.
• The widest annual swing landed in 2022, when Current Deferred Revenue gained 15.98%; it then dropped 20.59% in 2026.
• Tracing INGN's Current Deferred Revenue over 5 years: stood at $8.9 million in 2022, then declined by 10.14% to $8.0 million in 2023, then retreated by 16.62% to $6.7 million in 2024, then fell by 17.3% to $5.5 million in 2025, then dropped by 7.5% to $5.1 million in 2026.
• Per Business Quant, the three latest INGN Current Deferred Revenue figures stand at $5.1 million (Q1 2026), $5.5 million (Q4 2025), and $6.0 million (Q3 2025).

Peer Comparison